{"id":7631,"date":"2014-07-14T09:29:32","date_gmt":"2014-07-14T08:29:32","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=7631"},"modified":"2014-07-14T09:29:32","modified_gmt":"2014-07-14T08:29:32","slug":"actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","title":{"rendered":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica"},"content":{"rendered":"<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/07\/Portada-circular.jpg\"><img decoding=\"async\" class=\"alignright  wp-image-7634\" alt=\"Portada circular\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/07\/Portada-circular.jpg\" width=\"193\" height=\"253\" \/><\/a>Ja podeu llegir el<strong><span style=\"text-decoration: underline; color: #888888;\"> <a href=\"http:\/\/www.cofb.org\/c\/document_library\/get_file?uuid=2f0cde9f-be46-4edb-8072-0847d1d3c25f&amp;groupId=10136\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #888888; text-decoration: underline;\">nou n\u00famero de la revista cient\u00edfica del Col\u00b7legi<em> Circular Farmac\u00e8utica<\/em><\/span><\/a><\/span><\/strong>, corresponent al segon trimestre de 2014. L\u2019edici\u00f3 d\u2019enguany destaca l\u2019<strong>actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya,<\/strong> considerada una malaltia cr\u00f2nica potencialment incapacitant.<\/p>\n<p>Igual que ens les darreres edicions, s\u2019inclouen articles sobre farmacoter\u00e0pia, casos cl\u00ednics i altres continguts relacionats amb els diferents \u00e0mbits de la farm\u00e0cia.<\/p>\n<p>Us detallem els continguts d\u2019aquest n\u00famero de la revista a continuaci\u00f3:<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Editorial:<\/strong> T. Casas\u00edn<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Farmacoter\u00e0pia:<\/strong> Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Farmacoter\u00e0pia:<\/strong> L\u2019\u00fas hospitalari de les immunoglobulines inespec\u00edfiques intravenoses<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Espigolant<\/strong><\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Casos Cl\u00ednics:<\/strong> Tuberculosis multiresistent en pediatria\/ Tractament del pacient VIH debutant, amb coinfecci\u00f3 VHB<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Alimentaci\u00f3 i Nutrici\u00f3:<\/strong> Fitxes de consells nutricionals per a diferents problemes de salut<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Innovadors<\/strong><\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Vademecum Cultural<\/strong><\/p>\n<p><strong><span style=\"text-decoration: underline; color: #888888;\"><a href=\"http:\/\/www.cofb.org\/web\/guest\/circular-farmaceutica\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #888888; text-decoration: underline;\">Veure n\u00fameros anteriors de<em> Circular Farmac\u00e8utica<\/em><\/span><\/a><\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ja podeu llegir el nou n\u00famero de la revista cient\u00edfica del Col\u00b7legi Circular Farmac\u00e8utica, corresponent al segon trimestre de 2014. L\u2019edici\u00f3 d\u2019enguany destaca l\u2019actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, considerada una malaltia cr\u00f2nica potencialment incapacitant. Igual que ens les darreres edicions, s\u2019inclouen articles sobre farmacoter\u00e0pia, casos cl\u00ednics i altres [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7634,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[32],"tags":[2149],"class_list":["post-7631","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies-farmacia","tag-publicacions"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Ja podeu llegir el nou n\u00famero de la revista cient\u00edfica del Col\u00b7legi Circular Farmac\u00e8utica, corresponent al segon trimestre de 2014. L\u2019edici\u00f3 d\u2019enguany destaca l\u2019actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, considerada una malaltia cr\u00f2nica potencialment incapacitant. Igual que ens les darreres edicions, s\u2019inclouen articles sobre farmacoter\u00e0pia, casos cl\u00ednics i altres [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-07-14T08:29:32+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica\",\"datePublished\":\"2014-07-14T08:29:32+00:00\",\"dateModified\":\"2014-07-14T08:29:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\"},\"wordCount\":167,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Publicacions\"],\"articleSection\":[\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\",\"name\":\"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-07-14T08:29:32+00:00\",\"dateModified\":\"2014-07-14T08:29:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","og_locale":"ca_ES","og_type":"article","og_title":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Ja podeu llegir el nou n\u00famero de la revista cient\u00edfica del Col\u00b7legi Circular Farmac\u00e8utica, corresponent al segon trimestre de 2014. L\u2019edici\u00f3 d\u2019enguany destaca l\u2019actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, considerada una malaltia cr\u00f2nica potencialment incapacitant. Igual que ens les darreres edicions, s\u2019inclouen articles sobre farmacoter\u00e0pia, casos cl\u00ednics i altres [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-07-14T08:29:32+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica","datePublished":"2014-07-14T08:29:32+00:00","dateModified":"2014-07-14T08:29:32+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/"},"wordCount":167,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"thumbnailUrl":"","keywords":["Publicacions"],"articleSection":["Not\u00edcies farm\u00e0cia"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","url":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","name":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-07-14T08:29:32+00:00","dateModified":"2014-07-14T08:29:32+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Ja podeu llegir el nou n\u00famero de la revista cient\u00edfica del Col\u00b7legi Circular Farmac\u00e8utica, corresponent al segon trimestre de 2014. L\u2019edici\u00f3 d\u2019enguany destaca l\u2019actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, considerada una malaltia cr\u00f2nica potencialment incapacitant. Igual que ens les darreres edicions, s\u2019inclouen articles sobre farmacoter\u00e0pia, casos cl\u00ednics i altres [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/7631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=7631"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/7631\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=7631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=7631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=7631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}